In an exclusive interview with BioPharma Boardroom, Dr. Mehmood Khan, Chief Executive Officer of Hevolution Foundation, shares insights into the trends shaping the field of aging research in 2025. From drug repurposing and epigenetic breakthr... Read more
As the biopharma industry continues to evolve, sustainability has emerged as a key driver of progress. Ryan Walker, Sustainability Program Leader at Cytiva, highlights the company’s holistic approach to advancing sustainability through innov... Read more
In a detailed interview with BioPharma BoardRoom, Kerstin Pohl, Senior Global Marketing Manager for Gene Therapy & Nucleic Acid at SCIEX, delves into the analytical challenges gene therapy developers face as the field evolves in 2025. From addres... Read more
In a thought-provoking Q&A with BioPharma BoardRoom, Demaris Mills, President of Integrated DNA Technologies (IDT), discusses the transformative advancements shaping gene editing and DNA synthesis as we approach 2025. From overcoming delivery cha... Read more
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced that the humanized anti-solu... Read more
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") announced it has withdrawn its non-binding proposal to acquire Evotec SE (NASDAQ: EVO) ("Evotec") for €11.00 per share in cash, implying a fully diluted equity value of &eu... Read more
Lonza has provided an overview of its new “One Lonza” strategy and new organizational structure As Lonza focuses on its core CDMO1 business, it will exit the Capsules & Health Ingredients (CHI) business at the appropriate time an... Read more
Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, just completed significant expansions in Europe and the USA. The investments at its East Windsor, New Jersey, and Ringaskiddy, Cor... Read more
© 2024 Biopharma Boardroom. All Rights Reserved.
